Boxer Capital, LLC I Teos Therapeutics, Inc. Transaction History
Boxer Capital, LLC
- $1.92 Billion
- Q1 2024
A detailed history of Boxer Capital, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 1,804,058 shares of ITOS stock, worth $26.8 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
1,804,058
Previous 1,804,058
-0.0%
Holding current value
$26.8 Million
Previous $19.8 Million
24.57%
% of portfolio
1.28%
Previous 1.02%
Shares
4 transactions
Others Institutions Holding ITOS
# of Institutions
142Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Black Rock Inc. New York, NY4.11MShares$61.1 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$40.6 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$29.7 Million0.78% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$25.9 Million3.9% of portfolio
-
Morgan Stanley New York, NY1.63MShares$24.2 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $528M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...